{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:50:19Z","timestamp":1794559819872,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Health, Labor, and Welfare of Japan","award":["The Health and Labor Sciences Research Grant [19FE1003]"],"award-info":[{"award-number":["The Health and Labor Sciences Research Grant [19FE1003]"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The effects and their magnitudes of sex on disease activity indices for rheumatoid arthritis are not clear. We aimed to comprehensively evaluate the influence of sex on disease activity indices in the real-world setting using a large observational database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We analyzed 14,958 patients registered in the National Database of Rheumatic Diseases in Japan (NinJa) in 2017. We evaluated the sex differences in the 28-joint disease activity score (DAS28) using erythrocyte sedimentation rate (ESR), DAS28 using C-reactive protein (DAS28-CRP), Simplified Disease Activity Index (SDAI), and Clinical Disease Activity Index by disease activity category using Cliff\u2019s delta and regression analysis. Differences in the share of components of indices were evaluated using permutational multivariate analysis of variance. Correction equations were constructed to estimate the number of misclassification in male patients who achieve DAS28-ESR remission.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>DAS28-ESR showed higher values in female patients than male patients in remission despite no obvious difference in other indices or disease activity categories. Among the components of DAS28-ESR, only ESR was higher in female patients than male patients in remission. In DAS28-CRP and SDAI, 28-tender joint count was higher and CRP was lower in female patients than male patients. In addition, the profiles in the components were different between female and male patients, especially among those with high disease activity. Using correction equations, almost 12% of male patients with DAS28-ESR remission were estimated to be misclassified, mainly due to differences in ESR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Among the disease activity indices, significant sex difference was observed only in DAS28-ESR remission. The degree of misclassification in DAS28-ESR remission would be unignorable.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s41927-023-00328-9","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T12:03:06Z","timestamp":1679400186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comprehensive evaluation of the influence of sex differences on composite disease activity indices for rheumatoid arthritis: results from a nationwide observational cohort study"],"prefix":"10.1186","volume":"7","author":[{"given":"Takahiro","family":"Nishino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"328_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/annrheumdis-2015-207526","volume":"75","author":"MA Stoffer","year":"2016","unstructured":"Stoffer MA, Schoels MM, Smolen JS, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Ann Rheum Dis. 2016;75:16\u201322.","journal-title":"Ann Rheum Dis"},{"key":"328_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JWJ, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631\u20137.","journal-title":"Ann Rheum Dis"},{"key":"328_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320:1360\u201372.","journal-title":"JAMA"},{"key":"328_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"MLL Prevoo","year":"1995","unstructured":"Prevoo MLL, van'T Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44\u20138.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"328_CR5","first-page":"151","volume":"62","author":"J Fransen","year":"2004","unstructured":"Fransen J, Welsing PMJ, de Keijzer RMH, et al. Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis. 2004;62(Suppl 1):151.","journal-title":"Ann Rheum Dis"},{"key":"328_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003;42:244\u201357.","journal-title":"Rheumatology (Oxford)"},{"key":"328_CR7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1186\/ar1740","volume":"7","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Nell VPK, Stamm T, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7:796\u2013806.","journal-title":"Arthritis Res Ther"},{"key":"328_CR8","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/acr.24042","volume":"71","author":"BR England","year":"2019","unstructured":"England BR, Tiong BK, Bergman MJ, et al. 2019 update of the American College of Rheumatology recommended rheumatoid arthritis disease activity measures. Arthritis Care Res (Hoboken). 2019;71:1540\u201355.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"328_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1080\/03009740802241717","volume":"37","author":"B Rintelen","year":"2008","unstructured":"Rintelen B, Haindl PM, Maktari A, et al. SDAI\/CDAI levels in rheumatoid arthritis patients are highly dependent on patient\u2019s pain perception and gender. Scand J Rheumatol. 2008;37:410\u20133.","journal-title":"Scand J Rheumatol"},{"key":"328_CR10","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/ard.2007.079913","volume":"67","author":"BJ Radovits","year":"2008","unstructured":"Radovits BJ, Fransen J, van Riel PLCM, et al. Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis. Ann Rheum Dis. 2008;67:1127\u201331.","journal-title":"Ann Rheum Dis"},{"key":"328_CR11","first-page":"214","volume":"31","author":"B Tengstrand","year":"2004","unstructured":"Tengstrand B, Ahlm\u00e9n M, Hafstr\u00f6m I. The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years. J Rheumatol. 2004;31:214\u201322.","journal-title":"J Rheumatol"},{"issue":"1","key":"328_CR12","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/ar2591","volume":"11","author":"T Sokka","year":"2009","unstructured":"Sokka T, Toloza S, Cutolo M, et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther. 2009;11(1):R7.","journal-title":"Arthritis Res Ther"},{"key":"328_CR13","first-page":"2382","volume":"34","author":"BF Leeb","year":"2007","unstructured":"Leeb BF, Haindl PM, Maktari A, et al. Disease activity score-28 values differ considerably depending on patient\u2019s pain perception and sex. J Rheumatol. 2007;34:2382\u20137.","journal-title":"J Rheumatol"},{"key":"328_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/ard.2008.102244","volume":"69","author":"M Ahlm\u00e9n","year":"2010","unstructured":"Ahlm\u00e9n M, Svensson B, Albertsson K, et al. Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage. Ann Rheum Dis. 2010;69:230\u20133.","journal-title":"Ann Rheum Dis"},{"key":"328_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.105124","volume":"88","author":"S Shin","year":"2021","unstructured":"Shin S, Park EH, Kang EH, et al. Sex differences in clinical characteristics and their influence on clinical outcomes in an observational cohort of patients with rheumatoid arthritis. Joint Bone Spine. 2021;88:105124.","journal-title":"Joint Bone Spine"},{"key":"328_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3899\/jrheum.080724","volume":"36","author":"N Iikuni","year":"2009","unstructured":"Iikuni N, Sato E, Hoshi M, et al. The influence of sex on patients with rheumatoid arthritis in a large observational cohort. J Rheumatol. 2009;36:508\u201311.","journal-title":"J Rheumatol"},{"key":"328_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/s10165-010-0367-6","volume":"21","author":"T Matsui","year":"2011","unstructured":"Matsui T, Kuga Y, Nishino J, et al. Comparison of composite disease activity indices for rheumatoid arthritis. Mod Rheumatol. 2011;21:134\u201343.","journal-title":"Mod Rheumatol"},{"key":"328_CR18","first-page":"454","volume":"28","author":"D Jawaheer","year":"2010","unstructured":"Jawaheer D, Olsen J, Lahiff M, et al. Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA study. Clin Exp Rheumatol. 2010;28:454\u201361.","journal-title":"Clin Exp Rheumatol"},{"key":"328_CR19","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/acr.23229","volume":"69","author":"MD George","year":"2017","unstructured":"George MD, Giles JT, Katz PP, et al. Impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2017;69:1789\u201398.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"328_CR20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/art.24430","volume":"61","author":"A Ranzolin","year":"2009","unstructured":"Ranzolin A, Brenol JCT, Bredemeier M, et al. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2009;61:794\u2013800.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"328_CR21","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/s10067-019-04574-6","volume":"38","author":"E Ruiz-Medrano","year":"2019","unstructured":"Ruiz-Medrano E, Espinosa-Ortega HF, Arce-Salinas CA. The effect of concomitant hand osteoarthritis on pain and disease activity in patients with rheumatoid arthritis. Clin Rheumatol. 2019;38:2709\u201316.","journal-title":"Clin Rheumatol"},{"key":"328_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12016-018-8672-5","volume":"56","author":"EG Favalli","year":"2019","unstructured":"Favalli EG, Biggioggero M, Crotti C, et al. Sex and management of rheumatoid arthritis. Clin Rev Allergy Immunol. 2019;56:333\u201345.","journal-title":"Clin Rev Allergy Immunol"},{"key":"328_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2474-15-368","volume":"15","author":"L Siemons","year":"2014","unstructured":"Siemons L, Ten Klooster PM, Vonkeman HE, et al. How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis. BMC Musculoskelet Disord. 2014;15:1\u20137.","journal-title":"BMC Musculoskelet Disord"},{"key":"328_CR24","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/rheumatology\/key374","volume":"58","author":"PDH Hamann","year":"2019","unstructured":"Hamann PDH, Shaddick G, Hyrich K, et al. Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis.\u00a0Rheumatology (Oxford). 2019;58:831\u20135.","journal-title":"Rheumatology&nbsp;(Oxford)"},{"key":"328_CR25","first-page":"769","volume":"26","author":"I Castrej\u00f3n","year":"2008","unstructured":"Castrej\u00f3n I, Ortiz AM, Garc\u00eda-Vicu\u00f1a R, et al. Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? Clin Exp Rheumatol. 2008;26:769\u201375.","journal-title":"Clin Exp Rheumatol"},{"key":"328_CR26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/ard.2006.063834","volume":"66","author":"T Matsui","year":"2007","unstructured":"Matsui T, Kuga Y, Kaneko A, et al. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients. Ann Rheum Dis. 2007;66:1221\u20136.","journal-title":"Ann Rheum Dis"},{"key":"328_CR27","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10067-014-2538-x","volume":"33","author":"L Siemons","year":"2014","unstructured":"Siemons L, Vonkeman HE, Ten Klooster PM, et al. Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker. Clin Rheumatol. 2014;33:783\u20139.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"328_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1586\/eci.12.35","volume":"8","author":"Y Saeki","year":"2012","unstructured":"Saeki Y, Matsui T, Saisho K, et al. Current treatments of rheumatoid arthritis: from the \u201cNinJa\u201d registry. Expert Rev Clin Immunol. 2012;8(5):455\u201365.","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"328_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"328_CR30","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"328_CR31","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1136\/ard.2010.130310","volume":"69","author":"J Funovits","year":"2010","unstructured":"Funovits J, Aletaha D, Bykerk V, et al. The 2010 American College of Rheumatology\/European league against rheumatism classification criteria for rheumatoid arthritis: methodological report phase I. Ann Rheum Dis. 2010;69(9):1589\u201395.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"328_CR32","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1002\/art.27580","volume":"62","author":"T Neogi","year":"2010","unstructured":"Neogi T, Aletaha D, Silman AJ, et al. The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum. 2010;62(9):2582\u201391.","journal-title":"Arthritis Rheum"},{"key":"328_CR33","unstructured":"Romano J, Kromrey JD, Coraggio J, et al.: Exploring methods for evaluating group differences on the NSSE and other surveys: are the t-test and Cohen\u2019s d indices the most appropriate choices? Annu Meet South Assoc Institutional Res 2006:1\u201351."},{"key":"328_CR34","doi-asserted-by":"publisher","DOI":"10.1201\/9780429492259","volume-title":"Flexible imputation of missing data","author":"S van Buuren","year":"2018","unstructured":"van Buuren S. Flexible imputation of missing data. 2nd ed. Boca Raton, FL: Chapman and Hall\/CRC Press; 2018.","edition":"2"},{"key":"328_CR35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/bmj.286.6361.266","volume":"286(6361)","author":"A Miller","year":"1983","unstructured":"Miller A, Green M. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed). 1983;286(6361):266.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"328_CR36","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/ard.2007.084897","volume":"67","author":"H M\u00e4kinen","year":"2008","unstructured":"M\u00e4kinen H, Hannonen P, Sokka T. Sex: A major predictor of remission as measured by 28-joint Disease Activity Score (DAS28) in early rheumatoid arthritis? Ann Rheum Dis. 2008;67:1052\u20133.","journal-title":"Ann Rheum Dis"},{"key":"328_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/acr.22953","volume":"69","author":"MM Ward","year":"2017","unstructured":"Ward MM, Guthrie LC, Dasgupta A. Direct and indirect determinants of the patient global assessment in rheumatoid arthritis: differences by level of disease activity. Arthritis Care Res (Hoboken). 2017;69:323\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"328_CR38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jpain.2008.12.001","volume":"10","author":"RB Fillingim","year":"2009","unstructured":"Fillingim RB, King CD, Ribeiro-Dasilva MC, et al. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain. 2009;10:447\u201385.","journal-title":"J Pain"},{"key":"328_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116926","volume":"237","author":"SA Nasser","year":"2019","unstructured":"Nasser SA, Afify EA. Sex differences in pain and opioid mediated antinociception: modulatory role of gonadal hormones. Life Sci. 2019;237: 116926.","journal-title":"Life Sci"},{"key":"328_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.36076\/ppj\/2019.22.s1","volume":"22","author":"SH Wagemakers","year":"2019","unstructured":"Wagemakers SH, van der Velden JM, Gerlich AS, et al. A systematic review of devices and techniques that objectively measure patients\u2019 pain. Pain Physician. 2019;22:1\u201313.","journal-title":"Pain&nbsp;Physician"},{"key":"328_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/ard.2006.056937","volume":"66","author":"K Forslind","year":"2007","unstructured":"Forslind K, Hafstr\u00f6m I, Ahlm\u00e9n M, et al. Sex: A major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis. 2007;66:46\u201352.","journal-title":"Ann Rheum Dis"},{"key":"328_CR42","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10067-018-4340-7","volume":"38","author":"C Yu","year":"2019","unstructured":"Yu C, Jin S, Wang Y, et al. Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis. Clin Rheumatol. 2019;38:727\u201338.","journal-title":"Clin Rheumatol"},{"key":"328_CR43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/acr.23873","volume":"72","author":"C Maynard","year":"2020","unstructured":"Maynard C, Mikuls TR, Cannon GW, et al. Sex differences in the achievement of remission and low disease activity in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2020;72:326\u201333.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"328_CR44","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/rheumatology\/kez461","volume":"59","author":"E Nikiphorou","year":"2020","unstructured":"Nikiphorou E, Norton SJ, Carpenter L, et al. Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network. Rheumatology (Oxford). 2020;59:1272\u201380.","journal-title":"Rheumatology (Oxford)"},{"key":"328_CR45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13075-016-1151-6","volume":"18","author":"E Nikiphorou","year":"2016","unstructured":"Nikiphorou E, Radner H, Chatzidionysiou K, et al. Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature. Arthritis Res Ther. 2016;18:251.","journal-title":"Arthritis Res Ther"},{"key":"328_CR46","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/acr.23284","volume":"70","author":"RJO Ferreira","year":"2018","unstructured":"Ferreira RJO, Duarte C, Ndosi M, et al. Suppressing inflammation in rheumatoid arthritis: Does patient global assessment blur the target? A practice-based call for a paradigm change. Arthritis Care Res (Hoboken). 2018;70:369\u201378.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"328_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214199","volume":"78","author":"RJO Ferreira","year":"2019","unstructured":"Ferreira RJO, Ndosi M, de Wit M, et al. Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis. Ann Rheum Dis. 2019;78: e109.","journal-title":"Ann Rheum Dis"},{"key":"328_CR48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1136\/annrheumdis-2019-216529","volume":"79","author":"P Studenic","year":"2020","unstructured":"Studenic P, Felson D, de Wit M, et al. Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: Are the current ACR\/EULAR Boolean criteria optimal? Ann Rheum Dis. 2020;79:445\u201352.","journal-title":"Ann Rheum Dis"},{"key":"328_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24847","author":"M Doumen","year":"2021","unstructured":"Doumen M, de Cock D, Pazmino S, et al. Psychosocial burden predicts sustained remission in early rheumatoid arthritis: unraveling the complex interplay of wellbeing and disease activity. Arthritis Care Res (Hoboken). 2021. https:\/\/doi.org\/10.1002\/acr.24847.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"328_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac213","author":"S Pazmino","year":"2022","unstructured":"Pazmino S, Lovik A, Boonen A, et al. New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis.\u00a0Rheumatology (Oxford). 2022. https:\/\/doi.org\/10.1093\/rheumatology\/keac213.","journal-title":"Rheumatology&nbsp;(Oxford)"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-023-00328-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-023-00328-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-023-00328-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T19:15:20Z","timestamp":1729106120000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-023-00328-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["328"],"URL":"https:\/\/doi.org\/10.1186\/s41927-023-00328-9","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]},"assertion":[{"value":"23 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subjects. The ethics committee of National Hospital Organization Sagamihara National Hospital approved that this study is appropriate for the opt-out method according to ethical guidelines and allowed to waive the need of written informed consent. The NinJa project was reviewed and approved by the ethics committee of National Hospital Organization Sagamihara National Hospital (2014031816) and the ethics committees of participating institutions. The list of participating institutions: National Hospital Organization Tokyo National Hospital, National Hospital Organization Sagamihara National Hospital, National Hospital Organization Hokkaido Medical Center, Tsugaru General Hospital, National Hospital Organization Asahikawa Medical Center, National Hospital Organization Morioka Medical Center, Maebashi Hirosegawa Clinic, Faculty of Medicine, University of Tsukuba, University of Yamanashi Hospital, Saitama Medical University Hospital, Japanese Red Cross Ogawa Hospital, National Hospital Organization Shimoshizu National Hospital, Teikyo University Chiba Medical Center, Kohnodai Hospital, National Center for Global Health and Medicine, The University of Tokyo Hospital, National Hospital Organization Tokyo Medical Center, Tokyo Metropolitan Tama Medical Center, Tokyo Medical University Hospital, Tokyo Medical And Dental University Hospital, Tokyo Medical University Hachioji Medical Center, Tokyo Metropolitan Bokutoh Hospital, Soshigaya Okura Clinic, Tama-Hokubu Medical Center, Yokohama Rosai Hospital, National Hospital Organization Yokohama Medical Center, Niigata Rheumatic Center, Marunouchi Hospital, National Hospital Organization Awara Hospital, University of Toyama, Faculty of Medicine, National Hospital Organization Nagoya Medical Center, National Hospital Organization Osaka Minami Medical Center, National Hospital Organization Osaka Toneyama Medical Center, The Hospital of Hyogo College of Medicine, Amagasaki Health Co-operative Hospital, National Hospital Organization Himeji Medical Center, Kurashiki Medical Center, Oyama Clinic, Hiroshima University Hospital, National Hospital Organization Kochi National Hospital, National Hospital Organization Kyushu Medical Center, National Hospital Organization Fukuoka Hospital, National Hospital Organization Ureshino Medical Center, National Hospital Organization Nagasaki Medical Center, National Hospital Organization Beppu Medical Center, National Hospital Organization Miyakonojo Medical Center, Kumamoto Shinto General Hospital, Japanese Red Cross Kumamoto Hospital, Japanese Red Cross Kagoshima Hospital, Northern Okinawa Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TN and AH have no competing interests to disclose. ST has received grants from Pfizer Japan Inc., Mitsubishi-Tanabe Pharm Co., Daiichi Sankyo Co., Ltd., Chugai Pharmaceutical Co., Ltd., and AbbVie Japan Co., Ltd. and honorariums for speakers from Pfizer Japan Inc., Ono Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Astellas Pharm Inc., Ayumi Pharmaceutical, QIAGEN K. K., Mitsubishi-Tanabe Pharm Co., and AsahiKASEI Co., Ltd. TM has received grants from AbbVie Japan Co., Ltd., Asahi Kasei Pharma, Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Pfizer Inc., Mitsubishi-Tanabe Pharma Co., and Taisho Pharmaceutical Co., Ltd. and honorarium for lectures from AbbVie Japan Co., Ltd., Asahi Kasei Pharma, Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Mitsubishi-Tanabe Pharma Co., Ono Pharmaceutical, Pfizer Inc., Takeda Pharmaceutical Co., Ltd., and UCB Japan Co., Ltd.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}